Pharmacoeconomic analysis of perampanel for resistance partial epilepsy
Partial epilepsy is the most common type of seizures. Th e prevalence of partial epilepsy in Russia reached 325 thousand patients, with resistant to therapy about 276 thousand. Objective. Pharmacoeconomic analysis (PHe) was conducted for perampanel use in patients older than 14 years with resistance...
Saved in:
Main Authors: | D. Yu. Belousov (Author), E. V. Afanasyeva (Author), E. A. Efremova (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of adjuvant use of zonisamide therapy resistant partial epilepsy in adults
by: D. Yu. Belousov, et al.
Published: (2018) -
PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM
by: N. K. Mazina, et al.
Published: (2017) -
Pharmacoeconomic analysis of Movalis in patients with osteoarthritis and rheumatoid arthritis
by: E. S. Tsvetkova, et al.
Published: (2018) -
New drug classes for the treatment of partial onset epilepsy: focus on perampanel
by: Shih JJ, et al.
Published: (2013) -
Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson's disease
by: D. Yu. Belousov, et al.
Published: (2018)